ADCYAP1 and diabetic kidney disease: The nephroprotective effect of both exogenous and endogenous PACAP was revealed by numerous in vitro experiments in case of oxidative stress and hypoxia, drug induced nephropathies, diabetic nephropathy and myeloma kidney injury.